KR0164282B1 - Preparation method of phb by suppression of filamentation in recombinant escherichia coli - Google Patents

Preparation method of phb by suppression of filamentation in recombinant escherichia coli Download PDF

Info

Publication number
KR0164282B1
KR0164282B1 KR1019950017591A KR19950017591A KR0164282B1 KR 0164282 B1 KR0164282 B1 KR 0164282B1 KR 1019950017591 A KR1019950017591 A KR 1019950017591A KR 19950017591 A KR19950017591 A KR 19950017591A KR 0164282 B1 KR0164282 B1 KR 0164282B1
Authority
KR
South Korea
Prior art keywords
phb
escherichia coli
filamentation
coli
recombinant
Prior art date
Application number
KR1019950017591A
Other languages
Korean (ko)
Other versions
KR970001547A (en
Inventor
이상엽
Original Assignee
윤덕용
한국과학기술원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윤덕용, 한국과학기술원 filed Critical 윤덕용
Priority to KR1019950017591A priority Critical patent/KR0164282B1/en
Publication of KR970001547A publication Critical patent/KR970001547A/en
Application granted granted Critical
Publication of KR0164282B1 publication Critical patent/KR0164282B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • C12P7/625Polyesters of hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y202/00Transferases transferring aldehyde or ketonic groups (2.2)
    • C12Y202/01Transketolases and transaldolases (2.2.1)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 대장균의 필수 세포분열 단백질(ftsZ) 및 PHB(poly-3-hydroxybutyrate) 합성 유전자를 포함하는 재조합 플라스미드로 대장균(Escherichia coli)을 형질전환시키고, 이 형질전환체로부터 고농도의 PHB를 제조하는 방법에 관한 것이다. 본 발명의 PHB 제조방법에 의하면, 필라멘테이션을 억제할 수 있는 ftsZ를 과다발현시킴으로써, 재조합 대장균에 의한 PHB 생산시 균체가 필라멘테이션에 의해 길어져서 세포의 성장이 둔화 혹은 정지되어, PHB의 생산성 및 PHB 수율이 낮아지는 문제점을 해결하여, 경제적으로 고농도의 PHB를 제조할 수 있다.The present invention transforms Escherichia coli with a recombinant plasmid containing essential cell division protein (ftsZ) and poly-3-hydroxybutyrate (PHB) synthetic gene of Escherichia coli, and prepares a high concentration of PHB from the transformant. It is about a method. According to the PHB manufacturing method of the present invention, by overexpressing ftsZ, which can suppress filamentation, the cells are lengthened by filamentation during PHB production by recombinant E. coli, thereby slowing or stopping cell growth, Solving the problems of low productivity and low PHB yield, it is possible to economically produce a high concentration of PHB.

Description

필라멘테이션 억제에 의한 재조합 대장균으로부터 고농도 PHB(poly-3-hydroxybutyrate)를 제조하는 방법Method for preparing high concentration of poly-3-hydroxybutyrate (PHB) from recombinant E. coli by filamentation inhibition

제1도는 본 발명에서 제조한 재조합 플라스미드 pSYL107의 유전자 지도를 나타낸다.1 shows a genetic map of the recombinant plasmid pSYL107 prepared in the present invention.

제2(a)도는 37℃에서 배양한 재조합 대장균의 배양시간에 따른 건조균체, PHB 및 잉여건조균체 각각의 농도를 측정한 결과를 나타내는 그래프이다.Figure 2 (a) is a graph showing the results of measuring the concentration of each of the dry cells, PHB and surplus dry cells according to the culture time of the recombinant Escherichia coli cultured at 37 ℃.

제2(b)도는 30℃에서 배양한 재조합 대장균의 배양시간에 따른 건조균체, PHB 및 잉여건조균체 각각의 농도를 측정한 결과를 나타내는 그래프이다.Figure 2 (b) is a graph showing the results of measuring the concentration of each of the dry cells, PHB and surplus dry cells according to the culture time of the recombinant Escherichia coli cultured at 30 ℃.

본 발명은 필라멘테이션(filamentation) 억제에 의한 재조합 대장균으로부터 고농도 PHB(poly-3-hydroxybutyrate)를 제조하는 방법에 관한 것이다. 좀더 구체적으로 본 발명은 대장균의 필수 세포분열 단백질 유전자인 ftsZ 유전자를 포함하는 재조합 플라스미드로 대장균을 형질전환시킴으로써, 재조합 대장균에 의한 PHB 생산시 나타나는 필라멘테이션 현상을 억제하여, 재조합 대장균으로부터 고농도로 PHB를 제조하는 방법에 관한 것이다.The present invention relates to a method for producing high concentration of poly-3-hydroxybutyrate (PHB) from recombinant E. coli by inhibiting filamentation (filamentation). More specifically, the present invention transforms Escherichia coli into a recombinant plasmid containing the ftsZ gene, which is an essential cell division protein gene of Escherichia coli, thereby inhibiting the filamentation phenomenon that occurs during production of PHB by recombinant Escherichia coli, and thus, high concentration PHB from recombinant Escherichia coli. It relates to a method of manufacturing.

최근, 생분해성 고분자 재료로 각광받고 있는 PHB는 미생물에 의해 합성, 축적되는 에너지 저장물질이다. PHB는 기존의 화학합성 고분자와 물리·화학·기계적 성질이 비슷하고, 생체 적합성(biocompatibility) 및 생분해성이 우수하여 자연계에서 일정시간 경과하면 미생물에 의해 물과 이산화탄소로 완전분해가 되므로, 환경친화 플라스틱 원료로 각광을 받고 있다. 특히, PHB의 분해산물인 3-하이드록시부틸레이트(3-hydroxybutyrate)는 인간뿐만 아니라 동물의 체내에 존재하는 대사산물이어서 수술용 봉합사 및 약물 전달 시스템(drug delivery system) 등에의 용도로 개발되고 있으나, 높은 생산단가때문에 아직까지 범용의 포장제나 용기로는 사용되지 못하고 있다.Recently, PHB, which has been spotlighted as a biodegradable polymer material, is an energy storage material synthesized and accumulated by microorganisms. PHB has similar physical, chemical, and mechanical properties to existing chemical synthetic polymers, and has excellent biocompatibility and biodegradability, so it can be completely decomposed into water and carbon dioxide by microorganisms after a certain time in nature. It is attracting attention as a raw material. In particular, 3-hydroxybutyrate, a degradation product of PHB, is a metabolite present in the body of animals as well as humans, so it is being developed for use in surgical sutures and drug delivery systems. However, due to the high production cost, it is still not used as a general packaging or container.

따라서, PHB의 경제적인 생산을 위하여, PHB 생산균주로 알려진 알칼리게네스 유트로퍼스(Alacaligenes eutrophus)와 알칼리게네스 레이터스(Alcaligenes latus) 등이 집중적으로 연구되었고(참조: USP 4,433,053; Anderson and Daws, Microbiol. Rev., 54:450-472(1990)), 최근에는 몇몇의 연구자들에 의해 알칼리게네스 유트로퍼스의 PHB 합성 유전자를 대장균에 클로닝(cloning)함으로써 재조합 미생물에 의한 PHB의 생산도 가능하게 되었다(참조: WO 89/00202; Slater et al., J. Bacteriol., 170:4431-4436(1988); Schubert et al., J. Bacteriol., 170:5837-5847(1988); Peoples and Sinskey, J. Biol. Chem., 264:15298-15303(1989)).Therefore, for the economic production of PHB, Alkali genes eutrophus and Alcaligenes latus, known as PHB producing strains, have been intensively studied (see USP 4,433,053; Anderson and Daws). , Microbiol. Rev., 54: 450-472 (1990)), and recently, several researchers have shown the production of PHB by recombinant microorganisms by cloning the PHB synthetic gene of Alkaligenes eutropus to E. coli. WO 89/00202; Slater et al., J. Bacteriol., 170: 4431-4436 (1988); Schubert et al., J. Bacteriol., 170: 5837-5847 (1988); Peoples and Sinskey, J. Biol. Chem., 264: 15298-15303 (1989).

본 발명자 역시 재조합 대장균에 의해 경제적으로 PHB를 생산할 수 있는 방법을 강구하고자, 높은 복제수를 갖는 플라스미드(plasmid)의 개발, 플라스미드의 안정화, 형질전환용 균주의 개발, 재조합 미생물의 고농도 배양기술의 개발 및 PHB 합성 촉진을 위한 배양조건 확립 등에 대한 연구를 수행하여 왔다. 이러한 연구를 통하여, 복제수가 각기 다른 플라스미드 pSYl101 및 pSYL102, 이들을 안정화시키기 위하여 플라스미드 R1의 parB 영역(참조: Gerdes, Bio/Technol., 6:1402(1988))을 전기 플라스미드에 삽입시켜 제조한 pSYL103과 pSYL104를 대장균 XL1-Blue에 도입하여 PHB 합성능을 비교한 결과, 높은 복제수의 플라스미드를 사용하여야 PHB의 생산이 높음을 확인할 수 있었다(참조: Lee et al., Ann. NY Acad. Sci., 721:43-53(1994). Lee et al., J. Biotechnol., 32:203-211(1994)).In order to devise a method for producing PHB economically by recombinant Escherichia coli, the present inventors have also developed a plasmid having a high copy number, stabilization of the plasmid, development of transformation strain, development of high concentration culture technology of recombinant microorganism. And research has been carried out to establish the culture conditions for promoting PHB synthesis. Through these studies, the plasmids pSYl101 and pSYL102 with different numbers of copies, pSYL103 prepared by inserting the parB region of plasmid R1 (Gerdes, Bio / Technol., 6: 1402 (1988)) into the electric plasmid to stabilize them, pSYL104 was introduced into Escherichia coli XL1-Blue to compare PHB synthesis ability, and it was confirmed that high copy number plasmids were used to produce high PHB (Lee et al., Ann. NY Acad. Sci., 721: 43-53 (1994) Lee et al., J. Biotechnol., 32: 203-211 (1994).

또한, 대장균 XL1-Blue, 대장균 DH5α, 대장균 JM109, 대장균 B, 대장균 W, 대장균 K12 등 여러 종류의 대장균에 높은 복제수를 가지면서 안정한 플라스미드 pSYL105를 도입하여, PHB 합성속도 및 수율 등에 대한 연구를 수행한 결과, 균주특성에 따라 PHB 합성속도와 수율 등이 다름을 확인하였다(참조: Lee et al., Biotechnol. Bioeng., 44:1337-1347(1994)).In addition, a stable plasmid pSYL105 with high copy number was introduced to various types of Escherichia coli such as Escherichia coli XL1-Blue, Escherichia coli DH5α, Escherichia coli JM109, Escherichia coli B, Escherichia coli W, and Escherichia coli K12. As a result, it was confirmed that PHB synthesis rate and yield vary depending on the strain characteristics (Lee et al., Biotechnol. Bioeng., 44: 1337-1347 (1994)).

아울러, PHB 합성 촉진을 위한 재조합 미생물의 배양조건에 대한 연구를 통하여, 복합배지에 비해 저가의 단순배지에서는 PHB 합성능이 낮음을 알아내었다. 따라서, 경제적으로 고농도의 PHB를 제조할 수 있는 배양방법이 요구되었고, 이러한 방법으로 소량의 복합질소원이 첨가된 단순배지를 이용하는 방법이 제시되었으며, 트립톤(tryptone), 카사미노산(casamino acid) 혹은 카제인 가수분해물(casein hydrolysate) 등의 복합질소원을 소량(0.5 내지 5g/L) 첨가함으로써, PHB 합성을 증진시킬 수 있음을 확인하였다(참조: Lee and Chang, J. Environ. Polymer Degrad., 2:169-176(1994)). 또한 전기의 복합질소원 대신에 아미노산이나 올레산(oleic acid)의 첨가로도 PHB의 합성을 향상시킬 수 있음을 확인하였다(참조: Lee et al., J. Ferment. Bioeng., 79:177-180(1995)).In addition, through the study of the culture conditions of recombinant microorganisms for promoting PHB synthesis, it was found that PHB synthesis ability is lower in low-cost simple medium compared to the complex medium. Therefore, there was a need for a cultivation method capable of producing a high concentration of PHB economically, a method of using a simple medium with a small amount of complex nitrogen source was proposed in this way, tryptone, casamino acid (casamino acid) or It was confirmed that addition of small amounts (0.5 to 5 g / L) of complex nitrogen sources such as casein hydrolysate can enhance PHB synthesis (Lee and Chang, J. Environ. Polymer Degrad., 2: 169-176 (1994). In addition, it was confirmed that addition of amino acid or oleic acid may improve the synthesis of PHB instead of the former complex nitrogen source (Lee et al., J. Ferment. Bioeng., 79: 177-180 ( 1995)).

한편, PHB의 생산성을 높이기 위하여 유가식 배양법을 개발하여 39시간만에 건조균체 농도 101g/L, PHB 농도 81g/L를 얻을 수 있었다(참조: Lee et al., J. Biotechnol., 32:203-211(1994)). 또한, 복합질소원이 소량첨가된 단순배지에서도 유가식 배양에 의해 80g/L의 PHB를 얻을 수 있어서, 재조합 대장균에 의한 PHB의 생산이 매우 효과적임을 확인할 수 있었다(참조: Lee and Chang, J. Environ. Polymer Degrad., 2:169-176(1994)).Meanwhile, in order to increase the productivity of PHB, a fed-batch culture method was developed to obtain 101 g / L of dry cell concentration and 81 g / L of PHB concentration in 39 hours (Lee et al., J. Biotechnol., 32: 203). -211 (1994)). In addition, even a simple medium containing a small amount of complex nitrogen source can be obtained 80g / L PHB by fed-batch culture, it was confirmed that the production of PHB by recombinant E. coli is very effective (see Lee and Chang, J. Environ). Polymer Degrad., 2: 169-176 (1994)).

그러나, 재조합 대장균에 의한 단백질 발현시 일반적으로 필라멘테이션 현상이 관찰되는 바(참조: Schoner et al., Biotechnol., 3:151-154(1985); Rinas et al., J. Biotechnol., 28:313-320(1993)), 재조합 대장균에 의한 PHB 생산시 균체가 필라멘테이션에 의해 길어져서 세포의 성장이 둔화 혹은 정지되므로, 균체의 배양효율이 떨어질 뿐만 아니라, PHB의 생산성도 낮아진다는 문제점이 노출되어 왔다. 한편, 필라멘테이션의 정도는 대장균의 종류에 따라 다양한데, PHB를 가장 많이 축적하는 대장균 XL1-Blue의 경우 총 세포의 약 20% 정도가 8㎛ 이상 150㎛까지 길어졌으며, 대장균 DH5α, 대장균 JM109 등 다른 대장균 균주들도 PHB 축적시 필라멘테이션 현상을 나타내었다(참조: Lee et al., Biotechnol. Bioeng., 44:1337-1347(1994)).However, filamentation is generally observed in the expression of proteins by recombinant E. coli (Schoner et al., Biotechnol., 3: 151-154 (1985); Rinas et al., J. Biotechnol., 28 : 313-320 (1993)), when the production of PHB by recombinant E. coli is prolonged by filamentation, the growth of the cells is slowed down or stopped, resulting in a decrease in the culture efficiency of the cells and a decrease in the productivity of the PHB. This has been exposed. On the other hand, the degree of filamentation varies depending on the type of E. coli. In the case of Escherichia coli XL1-Blue, which accumulates the most PHB, about 20% of the total cells were extended to 8 μm or more and 150 μm, and E. coli DH5α, E. coli JM109, etc. Other E. coli strains also exhibited filamentation during PHB accumulation (Lee et al., Biotechnol. Bioeng., 44: 1337-1347 (1994)).

이에, 본 발명자는 재조합 대장균의 필라멘테이션 현상을 억제 또는 방지하기 위한 연구를 거듭한 결과, 필라멘테이션을 억제할 수 있는 필수 세포분열 단백질(ftsZ)의 유전자 및 PHB 유전자를 포함한 재조합 플라스미드를 제조하고, 이로 부터 형질전환된 재조합 대장균 필라멘테이션 현상을 나타내지 않으며, 고농도로 PHB를 제조할 수 있음을 발견하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have conducted research to inhibit or prevent the filamentation phenomenon of recombinant E. coli, thereby producing a recombinant plasmid containing a gene of essential cell division protein (ftsZ) and a PHB gene capable of inhibiting filamentation. From this, it was found that the transformed Escherichia coli filamentation phenomenon was not exhibited, and that PHB could be produced at a high concentration, thereby completing the present invention.

결국, 본 발명의 목적은 ftsZ 및 PHB 합성 유전자를 포함하는 재조합 플라스미드로 대장균을 형질전환시키고, 이 형질전환체로부터 고농도의 PHB를 제조하는 방법을 제공하는 것이다.After all, it is an object of the present invention to provide a method for transforming Escherichia coli with a recombinant plasmid containing ftsZ and PHB synthetic genes, and producing a high concentration of PHB from the transformant.

이하, 본 발명을 보다 구체적으로 설명하고자 한다.Hereinafter, the present invention will be described in more detail.

우선, 필라멘테이션 현상을 억제 또는 방지할 수 있는 대장균 ftsZ 유전자를 얻기 위하여, 플라스미드 pZAQ(참조: Ward and Lutkenhaus, Cell, 42:941-945(1985)에 제한요소 Hind Ⅲ 및 Cla Ⅰ을 처리하여 ftsZ 유전자를 포함한 2.1kb DNA 단편을 수득하였다. 그런 다음, 알칼리게네스 유트로퍼스의 PHB 합성 유전자가 클로닝된 높은 복제수의 안정한 플라스미드인 pSYL105(참조: Lee et al., Biotechnol., 44:1337-1347(1994))를 제한효소 HindⅢ 및 Cla Ⅰ으로 절단하고, 전기에서 수득한 2.1kb DNA 단편을 삽입하여 재조합 플라스미드 pSYL107을 제조하였다.First, in order to obtain an E. coli ftsZ gene capable of inhibiting or preventing filamentation, plasmids pZAQ (Ward and Lutkenhaus, Cell, 42: 941-945 (1985)) were treated with restriction elements Hind III and Cla I. A 2.1 kb DNA fragment containing the ftsZ gene was then obtained, followed by pSYL105 (Lee et al., Biotechnol., 44: 1337), a high-copy-stable stable plasmid cloned with an alkaline gene Eutropus PHB synthetic gene. -1347 (1994)) was digested with restriction enzymes HindIII and Cla I and recombinant plasmid pSYL107 was prepared by inserting the 2.1 kb DNA fragment obtained previously.

전기에서 제조된 pSYL107를 대장균에 도입한 다음, 재조합 대장균을 단순배지(KH2PO413.5g/L, (NH4)2HPO44g/L, MgSO4·7H2O 1.4g/L, 시트로산(citric acid) 1.7g/L, FeSO4·7H2O 0.1g/L, ZnSO4·7H2O 0.022g/L, CaCl2·2H2O 0.02g/L, CuSO4·5H2O 0.01g/L, MnSO4·4H2O 0.005g/L, Na2B4O7·10H2O 0.002g/L, (NH4)6Mo7O24·4H2O 0.001g/L, 티아민(thiamine) 0.01g/L 및 포도당 20g/L로 구성된 배치), 복합배지(트립톤(tryptone) 10g/L, 효모 추출물(yeast extract) 5g/L, NaCl 10g/L 및 포도당 20g/L로 구성된 배지) 또는 복합질소원이 0.1 내지 10g/L 첨가된 전기 단순배지에서 배양한 다음, 필라멘테이션의 정도, 균체성장, PHB 생산능 및 PHB 수율(g PHB/g 포도당)을 측정하여, 그 결과를 ftsZ 합성 유전자를 포함하고 있지 않는 pSYL105(참조: Lee et. al., Biotechnol., 44:1337-1347(1994))로 형질전환된 대장균과 비교하였다. 상기에서, 복합질소원으로는 트립톤, 효모 추출물, 펩톤(peptone), 카사미노산(casamino acid), 코튼 시드 가수분해물(cotton seed hydrolysate), 육즙 추출물(beef extract), 카제인 가수분해물(casein hydrolysate), 콜라겐 가수분해물(collagen hydrolysate), 콘스팁리커(corn steep liquor) 또는 소이빈 가수분해물(soybean hydrolysate) 등이 사용될 수 있다.PSYL107 prepared in advance was introduced into Escherichia coli, and then recombinant E. coli was transferred to simple medium (KH 2 PO 4 13.5 g / L, (NH 4 ) 2 HPO 4 4 g / L, MgSO 4 · 7H 2 O 1.4 g / L, sheet Citric acid 1.7g / L, FeSO 4 · 7H 2 O 0.1g / L, ZnSO 4 · 7H 2 O 0.022g / L, CaCl 2 · 2H 2 O 0.02g / L, CuSO 4 · 5H 2 O 0.01 g / L, MnSO 4 4 H 2 O 0.005 g / L, Na 2 B 4 O 7 10 H 2 O 0.002 g / L, (NH 4 ) 6 Mo 7 O 24 4H 2 O 0.001 g / L, thiamine batch consisting of 0.01 g / L thiamine and 20 g / L glucose, combined medium (tryptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L and glucose 20 g / L) Medium) or an electric simple medium containing 0.1 to 10 g / L of a complex nitrogen source, and then the degree of filamentation, cell growth, PHB production capacity and PHB yield (g PHB / g glucose) were measured. Compared to E. coli transformed with pSYL105 (Lee et. al., Biotechnol., 44: 1337-1347 (1994)) does not contain the ftsZ synthetic gene. In the above, the complex nitrogen source is tryptone, yeast extract, peptone, casamino acid, cotton seed hydrolysate, bee extract, casein hydrolysate, Collagen hydrolysate, corn steep liquor or soybean hydrolysate may be used.

상기의 필라멘테이션 억제정도, 균체성장, PHB 생산능 및 PHB 수율을 비교한 결과, 본 발명의 ftsZ 유전자를 포함한 재조합 플라스미드 pSYL107로 형질전환된 대장균은 필라멘테이션 현상이 억제 또는 방지되고, 균체성장, 분자량 100만 이상인 재조합 PHB 생산능 및 PHB 수율(g PHB/g 포도당)이 pSYL105로 형질전환된 대장균보다 월등히 우수함을 확인하였다. 또한, 본 발명에서 제조된 재조합 PHB는 일반적으로 분자량이 50 내지 80만인 종래의 PHB와는 아주 상이한 신규의 고분자였다.As a result of comparing the degree of filamentation inhibition, cell growth, PHB production capacity and PHB yield, E. coli transformed with the recombinant plasmid pSYL107 containing the ftsZ gene of the present invention, filamentation phenomenon is inhibited or prevented, cell growth , It was confirmed that the recombinant PHB production capacity and the PHB yield (g PHB / g glucose) having a molecular weight of 1 million or more is significantly superior to E. coli transformed with pSYL105. In addition, the recombinant PHB produced in the present invention was a novel polymer, which is very different from the conventional PHB, which generally has a molecular weight of 50 to 800,000.

따라서, 필라멘테이션이 억제·방지된 본 발명의 재조합 플라스미드를 함유한 재조합 대장균의 배양에 의해, PHB 합성능과 PHB 수율을 증대시킬 수 있고, 특히, 저가의 단순배지나 복합질소원이 첨가된 단순배지에서 PHB 합성능과 PHB 수율을 더욱 증대시킬 수 있음을 확인하였다.Therefore, by culturing the recombinant Escherichia coli containing the recombinant plasmid of the present invention in which filamentation is suppressed and prevented, it is possible to increase the PHB synthesis ability and the PHB yield, and in particular, a simple medium containing a low cost simple medium or a complex nitrogen source. It was confirmed that the medium can further increase the PHB synthesis ability and PHB yield.

한편, ftsZ 유전자가 증폭된 재조합 대장균을 37℃에서 배양할 경우, 미니셀(minicell)을 형성하여 균주가 불안정하게 된다는 보고가 있으므로(참조: Ward and Lutkenhaus, Cell, 42:941-947(1985)), 본 발명의 재조합 플라스미드 pSYL107로 형질전환된 대장균 균주를 전기의 여러가지 배양배지에서 37℃의 온도로 배양한 결과, 복합배지에서 배양된 균주만 미니셀을 형성하여, 균체의 성장이 느리고 PHB를 적게 생산함을 확인하였다. 따라서, 본 발명의 재조합 플라스미드로 형질전환된 대장균 균주는 20℃ 내지 40℃, 보다 바람직하게는 25℃ 내지 35℃의 온도범위에서 배양하는 것이 바람직함을 알 수 있다.On the other hand, when the recombinant Escherichia coli amplified ftsZ gene is incubated at 37 ℃, there is a report that the strain becomes unstable by forming a minicell (Ward and Lutkenhaus, Cell, 42: 941-947 (1985)) , When the E. coli strain transformed with the recombinant plasmid pSYL107 of the present invention was cultured at a temperature of 37 ° C. in various culture mediums as described above, only strains cultured in a complex medium formed minicells, resulting in slow growth of cells and low production of PHB. It was confirmed. Therefore, it can be seen that the E. coli strain transformed with the recombinant plasmid of the present invention is preferably cultured in a temperature range of 20 ℃ to 40 ℃, more preferably 25 ℃ to 35 ℃.

본 발명의 PHB 제조방법에 의하면, 필라멘테이션을 억제할 수 있는 ftsZ를 과다발현시킴으로써, 재조합 대장균에 의한 PHB 생산시 균체가 필라멘테이션에 의해 길어져서 세포의 성장이 둔화 혹은 정지되어, PHB의 생산성 및 PHB 수율도 낮아지는 문제점을 해결하여, 경제적으로 고농도의 PHB를 제조할 수 있다.According to the PHB manufacturing method of the present invention, by overexpressing ftsZ, which can suppress filamentation, the cells are lengthened by filamentation during PHB production by recombinant E. coli, thereby slowing or stopping cell growth, Solving the problem of lowering productivity and PHB yield, it is possible to economically produce a high concentration of PHB.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. 특히, 본 발명의 취지에 따라, 실시예에 예시한 ftsZ 및 PHB 합성 유전자를 동시에 함유하는 재조합 플라스미드를 이용하여 PHB를 고농도로 제조하는 방법 뿐만 아니라, 이들 유전자를 각각 함유하는 재조합 플라스미드로 대장균을 동시에 형질전환시켜 PHB를 제조하는 방법도 본 발명의 범주에 속한다고 보아야 할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, and it will be apparent to those skilled in the art that the scope of the present invention is not limited to these examples according to the gist of the present invention. In particular, according to the purpose of the present invention, not only a method for producing PHB in high concentration using recombinant plasmids containing the ftsZ and PHB synthetic genes exemplified in the examples, but also a recombinant plasmid containing each of these genes at the same time It will be appreciated that methods of producing PHB by transformation also fall within the scope of the present invention.

실시예 1 : 재조합 플라스미드 pSYL107의 제조Example 1 Preparation of Recombinant Plasmid pSYL107

재조합 대장균의 필라멘테이션 현상을 억제 또는 방지하기 위하여, ftsZ 및 PHB 합성 유전자를 포함한 플라스미드 pSYL107을 다음과 같이 제조하였다: 우선, 대장균의 ftsZ 유전자를 얻기 위하여, 플라스미드 pZAQ(참조: Ward and Lutkenhaus, Cell, 42:941-945(1985))에 제한효소 Hind Ⅲ 및 Cla Ⅰ을 처리하여 ftsZ 유전자를 포함한 2.1kb DNA 단편을 수득하였다. 그런 다음, 알칼리게네스 유트로퍼스의 PHB 합성 유전자를 플라스미드 pBluescript KS-(Stratagene, USA)의 SmaⅠ-EcoRⅠ 제한효소 부위에 알칼리게네스 유트로퍼스의 5.2kbp PHB 합성 유전자가 삽입된 8.2kbp의 pSK2665를 얻은 다음(참조: Schubert et al., J. Bacteriol., 173:168(1991)), 제한효소 EcoRⅠ 및 HindⅢ로 pSK2665를 절단하고 이 부위에 0.6kb의 parB 영역을 삽입하여 얻었다. 클로닝된 높은 복제수의 안정한 플라스미드인 pSYL105(참조: Lee et al., Biotechnol., 44:1337-1347(1994))를 제한효소 HindⅢ 및 Cla Ⅰ으로 절단하고, 전기에서 수득한 2.1kb DNA 단편을 삽입하여 재조합 플라스미드 pSYL107을 제조하였다. pSYL107은 10.9kb의 플라스미드로서, pSYL107의 유전자 지도를 제1도에 나타내었다.In order to inhibit or prevent the filamentation of recombinant E. coli, plasmid pSYL107 containing the ftsZ and PHB synthetic genes was prepared as follows: First, to obtain the ftsZ gene of E. coli, plasmid pZAQ (see Ward and Lutkenhaus, Cell) , 42: 941-945 (1985)) were treated with restriction enzymes Hind III and Cla I to obtain a 2.1 kb DNA fragment containing the ftsZ gene. The PHB synthesizing gene of Alkaligenes eutropus was then inserted into the SmaI-EcoRI restriction enzyme site of plasmid pBluescript KS- (Stratagene, USA). Was obtained (see Schubert et al., J. Bacteriol., 173: 168 (1991)), pSK2665 was digested with restriction enzymes EcoRI and HindIII and inserted into the region with 0.6 kb of parB region. PSYL105 (Lee et al., Biotechnol., 44: 1337-1347 (1994)), a cloned high copy number stable plasmid, was digested with restriction enzymes HindIII and Cla I and the 2.1 kb DNA fragment obtained from the above was obtained. Recombinant plasmid pSYL107 was prepared by insertion. pSYL107 is a plasmid of 10.9 kb, and a gene map of pSYL107 is shown in FIG.

전기에서 제조된 pSYL107를 대장균 XL1-Blue, 대장균 DH5α, 대장균 JM109, 대장균 B 및 대장균 W 등의 대장균에 도입한 다음, 필라멘테이션 억제 및 PHB 생산 정도를 비교한 결과, pSYL107로 형질전환된 대장균 XL1-Blue가 필라멘테이션 현상이 억제되면서 가장 많은 양의 PHB를 축적하는 대장균임을 확인하였다. 따라서, 하기의 실시예는 재조합 대장균으로 pSYL107로 형질전환된 대장균 XL1-Blue를 사용하였다.PSYL107 prepared in the above was introduced into Escherichia coli such as Escherichia coli XL1-Blue, Escherichia coli DH5α, Escherichia coli JM109, Escherichia coli B, and Escherichia coli W, and compared with the degree of filamentation inhibition and PHB production. -Blue was confirmed to be E. coli accumulating the largest amount of PHB as filamentation is suppressed. Therefore, the following example used Escherichia coli XL1-Blue transformed with pSYL107 as the recombinant Escherichia coli.

실시예 2 : 재조합 대장균에 의한 필라멘테이션 억제정도 측정Example 2 Measurement of Filamentation Inhibition Degree by Recombinant Escherichia Coli

재조합 대장균의 필라멘테이션 억제정도를 측정한 결과, pSYL105를 함유한 대장균 XL1-Blue는 복합배지에서 배양시 PHB를 합성 축적하는 과정에서 필라멘테이션 현상을 보였으나, ftsZ 유전자가 클로닝된 pSYL107를 함유한 대장균 XL1-Blue는 복합배지에서 배양시 필라멘테이션이 전혀 일어나지 않았고, 균체길이가 4㎛ 이하로 보통 대장균과 비슷하거나 약간 작았다.As a result of measuring the degree of filamentation inhibition of recombinant Escherichia coli, Escherichia coli XL1-Blue containing pSYL105 showed a filamentation phenomenon in the process of synthesizing PHB when cultured in complex medium, but containing pSYL107 cloned with ftsZ gene. One Escherichia coli XL1-Blue showed no filamentation at all when cultured in a mixed medium, and had a cell length of 4 µm or less, similar to or slightly smaller than that of E. coli.

또한, pSYL107를 함유한 대장균 XL1-Blue를 단순배지에서 배양할 경우, 약간의 필라멘테이션이 일어났으나, 그 정도는 pSYL105를 함유한 대장균 XL1-Blue와 비교하여 훨씬 적은 편으로, 약 5% 혹은 그 이하의 세포만이 필라멘테이션 현상을 나타내었다. ftsZ 유전자 증폭 후에도 단순배지에서 약간의 필라멘테이션이 일어난 것은 단순배지에서의 ftsZ 단백질 발현이 복합배지에서 보다 상대적으로 적어서 필라멘테이션을 완전히 억제하지 못하기 때문인 것으로 추정된다.In addition, when filamentous Escherichia coli XL1-Blue containing pSYL107 was cultured in a simple medium, some filamentation occurred, but the amount was much smaller than that of Escherichia coli XL1-Blue containing pSYL105, about 5%. Only cells below or below showed filamentation. The slight filamentation in the simple medium even after the amplification of the ftsZ gene is presumed to be due to the fact that ftsZ protein expression in the simple medium is relatively less than that in the complex medium, which does not completely inhibit the filamentation.

따라서, ftsZ 유전자가 클로닝된 pSYL107를 함유한 대장균 XL1-Blue는 ftsZ 단백질을 과다발현하여, 필라멘테이션을 상당부분 억제 혹은 완전히 방지할 수 있음을 알 수 있었다.Therefore, E. coli XL1-Blue containing pSYL107 cloned ftsZ gene overexpressed the ftsZ protein, it can be seen that it can significantly inhibit or completely prevent filamentation.

상기에서 사용된 단순배지 및 복합배지의 조성을 각각 하기 표 1과 표 2에 나타내었다.The composition of the simple medium and the composite medium used above are shown in Table 1 and Table 2, respectively.

실시예 3 : 필라멘테이션의 발생유무에 따른 균체성장 및 PHB 생산능 비교Example 3 Comparison of Cell Growth and PHB Production Capacity with and without Filamentation

필라멘테이션이 억제되는 pSYL107를 함유한 대장균 XL1-Blue 및 필라멘테이션이 일어나는 pSYL105를 함유한 대장균 XL1-Blue를 각각 50㎖의 복합배지와 단순배지가 담긴 250㎖ 플라스크에서 30℃ 혹은 37℃의 온도조건 및 300rpm으로 진탕배양한 다음, 건조균체 농도, PHB 농도 및 PHB 함량을 측정하였다. 이때, PHB 농도는 브로네그(Braunegg) 등의 방법으로 측정하였다(참조: Braunegg et al., Eur. J. Appl. Microbiol. Biotechnol., 6:29-37(1978)). 아울러, 복합배지에서는 48시간, 단순배지에서는 60시간 배양한 결과를 하기 표 3에 나타내었으며, PHB 함량은 PHB 농도 대 건조균체 농도비의 백분율(%)로 정의하였다.E. coli XL1-Blue containing pSYL107, which inhibits filamentation, and E. coli XL1-Blue containing pSYL105, which filamentation occurs, respectively, in 30 ml or 37 ° C in a 250 ml flask containing 50 ml of mixed medium and simple medium. After shaking culture at temperature and 300rpm, the dry cell concentration, PHB concentration and PHB content were measured. At this time, the PHB concentration was measured by the method of Braunegg et al. (Braunegg et al., Eur. J. Appl. Microbiol. Biotechnol., 6: 29-37 (1978)). In addition, the result of incubation for 48 hours in complex medium, 60 hours in simple medium is shown in Table 3 below, PHB content was defined as the percentage (%) of PHB concentration to dry cell concentration ratio.

상기 표 3에서 보듯이, 복합배지를 이용하고 30℃에서 배양한 pSYL107을 함유한 대장균 XL1-Blue는 동일한 조건에서 배양한 pSYL105를 함유한 대장균 XL1-Blue보다 균체의 성장과 PHB의 생산능이 우수하였고, PHB 함량은 무려 85.5%인 것으로 밝혀졌다. 또한, 복합배지를 이용하고 37℃에서 배양할 시는 이미 기술한 대로 미니셀의 형성으로 인하여, pSYL107을 함유한 대장균 XL1-Blue는 pSYL105를 함유한 대장균 XL1-Blue보다 균체의 농도도 낮고 PHB를 적게 생산함을 알 수 있었다.As shown in Table 3, Escherichia coli XL1-Blue containing pSYL107 cultured at 30 ° C. using a composite medium had better cell growth and PHB production capacity than Escherichia coli XL1-Blue containing pSYL105. , PHB content was found to be 85.5%. In addition, when cultured at 37 ° C. using a mixed medium, Escherichia coli XL1-Blue containing pSYL107 had a lower cell concentration and less PHB than Escherichia coli XL1-Blue containing pSYL105 due to the formation of minicells as described above. It was produced.

아울러, 필라멘테이션 억제에 의한 균체의 성장 및 PHB 함량은 단순배지에서 더욱 두드러져서, 30℃나 37℃ 두 경우 모두에서 pSYL107을 함유한 XL1-Blue가 pSYL105를 함유한 대장균 XL1-Blue보다 균체의 성장이 빠르고 두배 이상의 PHB를 생산하였고, 30℃에서 배양시 PHB 함량은 71.7%로 매우 높았다. 이것은 복합배지보다 가격이 월등히 저렴한 단순배지에서도 PHB를 효과적으로 생산할 수 있음을 의미한다.In addition, cell growth and PHB content by filamentation inhibition were more prominent in simple medium, so that XL1-Blue containing pSYL107 was higher than Escherichia coli XL1-Blue containing pSYL105 at both 30 ° C and 37 ° C. Fast growth and more than twice the production of PHB, PHB content was very high (71.7%) when incubated at 30 ℃. This means that PHB can be produced effectively even in simple medium, which is much cheaper than compound medium.

실시예 4 : 복합배지에서 배양온도에 따른 재조합 대장균 XL1-Blue의 PHB 합성 특성Example 4 PHB Synthesis Characteristics of Recombinant Escherichia Coli XL1-Blue According to Culture Temperature in Complex Medium

ftsZ 유전자가 증폭된 재조합 대장균은 미니셀을 형성하여 균주가 불안정하게 되므로, pSYL107로 형질전환된 대장균 XL1-Blue를 복합배지에서 배양하면서, 배양온도에 따른 PHB 합성의 특성을 조사하여, 적합한 배양온도를 결정하고자 하였다(참조: 제2(a)도 및 제2(b)도). 제2(a)도 및 제2(b)도는 37℃ 및 30℃에서 각각 배양한 재조합 대장균의 배양시간에 따른 건조균체, PHB 및 잉여건조균체(건조균체에서 PHB를 제외한 것) 각각의 농도를 측정한 결과를 나타내는 그래프이다.Since the recombinant Escherichia coli amplified ftsZ gene forms a minicell and the strain becomes unstable, while culturing Escherichia coli XL1-Blue transformed with pSYL107 in a complex medium, the characteristics of PHB synthesis according to the culture temperature are investigated, Decision was made (see FIGS. 2 (a) and 2 (b)). 2 (a) and 2 (b) show the concentrations of dry cells, PHB and surplus dry cells (excluding PHB in dry cells) according to the incubation time of recombinant E. coli cultured at 37 ° C. and 30 ° C., respectively. It is a graph showing the result of a measurement.

제2(a)도 및 제2(b)도에서 보듯이, 배양온도가 달라짐으로써 균체성장과 PHB 합성능이 현저히 다름을 알 수 있는데, 30℃에서의 배양으로 37℃에서의 배양보다 최종 건조균체 농도와 PHB 농도가 두배 이상 증가됨을 알 수 있다. 또한, 최대 PHB 합성속도는 37℃에서 각각 0.207g PHB/g 잉여건조균체와 0.191g PHB/g 잉여건조균체로 37℃에서 약간 빨랐지만, 배양이 진행됨에 따라 두가지 온도조건 모두에서 PHB 합성속도가 감소하였는데, 약 35시간 배양후 37℃와 30℃에서 PHB 합성속도는 각각 0.040g PHB/g 잉여건조균체와 0.106g PHB/g 잉여건조균체로, 37℃에서의 PHB 합성속도가 더욱 빨리 감소함을 알 수 있었다. 이때, PHB 합성속도는 시간당그램(gram) 잉여 건조균체당 생성된 그램 PHB로 정의하였다.As shown in FIG. 2 (a) and FIG. 2 (b), it can be seen that the cell growth and PHB synthesis ability are significantly different due to the different incubation temperature. It can be seen that concentration and PHB concentration are more than doubled. The maximum PHB synthesis rate was 0.207g PHB / g surplus dry cell and 0.191g PHB / g surplus dry cell at 37 ° C, respectively, but it was slightly faster at 37 ° C. After about 35 hours of incubation, the PHB synthesis rate at 37 ℃ and 30 ℃ was 0.040g PHB / g surplus dry cell and 0.106g PHB / g surplus dry cell, respectively. And it was found. At this time, the PHB synthesis rate was defined as the gram PHB produced per gram excess dry cells per hour.

따라서, 필라멘테이션이 억제된 재조합 대장균을 이용하여 PHB를 생산할 때는 보통 사용되는 배양온도 37℃보다 30℃가 더 적합한 배양온도이며, 20℃ 내지 40℃, 보다 바람직하게는 25℃ 내지 35℃의 온도범위에서 배양하는 것이 적절함을 확인하였다.Therefore, when producing PHB using the recombinant filamentation suppressed Escherichia coli, 30 ° C is more suitable than the culture temperature 37 ° C, which is usually used, 20 ° C to 40 ° C, more preferably 25 ° C to 35 ° C It was confirmed that the culture in the temperature range is appropriate.

실시예 5 : 복합질소원이 첨가된 단순배지에서의 PHB 생산능 측정Example 5 Determination of PHB Production Capacity in Simple Medium Added Complex Nitrogen

상기 표 3으로부터, 복합배지 및 37℃의 배양조건을 제외하고는 배치의 종류 및 배양온도에 관계없이, 필라멘테이션이 일어나지 않는 pSYL107를 함유한 대장균 XL1-Blue는 필라멘테이션이 일어나는 pSYL105를 함유한 대장균 XL1-Blue보다 고농도의 PHB를 생산할 수 있음을 확인하였다.From Table 3, E. coli XL1-Blue containing pSYL107 without filamentation, containing pSYL105 with filamentation, regardless of the type of the batch and the culture temperature, except for the complex medium and the culture conditions at 37 ° C It was confirmed that it can produce a higher concentration of PHB than E. coli XL1-Blue.

이와 관련하여, pSYL107를 함유한 대장균 XL1-Blue를 저가의 단순배지에서 배양하여 PHB 농도를 증가시킬 수 있으면, PHB 생산단가를 더욱 낮출 수 있을 것이므로, 하기 표 4의 복합질소원이 소량 첨가된 단순배지에서 pSYL107를 함유한 대장균 XL1-Blue를 배양하고자 하였다. 우선, 가장 높은 PHB 농도를 나타내는 복합질소원의 최적첨가 농도를 결정한 다음, 이 농도의 복합질소원을 포함한 단순배지에서 pSYL107를 함유한 대장균 XL1-Blue를 배양하여 균체성장 및 PHB 생산능을 측정하였다.In this regard, if Escherichia coli XL1-Blue containing pSYL107 can be cultured in a low-cost simple medium to increase the PHB concentration, the PHB production cost can be further lowered. E. coli XL1-Blue containing pSYL107 at First, the optimal concentration of the composite nitrogen source showing the highest PHB concentration was determined, followed by culturing Escherichia coli XL1-Blue containing pSYL107 in a simple medium containing the compound nitrogen source of this concentration to measure the cell growth and PHB production capacity.

실시예 5-1 : 복합질소원의 최적첨가 농도 결정Example 5-1 Determination of Optimal Concentration of Complex Nitrogen Sources

우선, 상기 표 4에 나타낸 10가지 복합질소원을 0.5 내지 5g/L로 변화시키면서 단순배지에 첨가한 다음, pSYL107를 함유한 대장균 XL1-Blue를 접종하여 60시간 동안 30℃에서 배양하고, 건조균체 및 PHB 농도를 측정하였다. 그런 다음, 각각의 복합질소원에 대해 가장 높은 PHB 농도를 나타내는 복합질소원의 농도를 최적첨가 농도로 하였으며, 그 결과를 하기 표 5에 나타내었다.First, the ten complex nitrogen sources shown in Table 4 were added to simple medium while changing to 0.5 to 5 g / L, and then inoculated with Escherichia coli XL1-Blue containing pSYL107 and incubated at 30 ° C. for 60 hours, and dried cells and PHB concentration was measured. Then, the concentration of the composite nitrogen source showing the highest PHB concentration for each composite nitrogen source was the optimal addition concentration, and the results are shown in Table 5 below.

실시예 5-2 : 복합질소원 첨가에 의한 PHB 생산능 측정Example 5-2 Measurement of PHB Production Capacity by Addition of Complex Nitrogen Source

실시예 5-1에서 결정한 최적첨가 농도로 복합질소원을 단순배지에 첨가한 다음, pSYL107를 함유한 대장균 XL1-Blue를 접종하여 48시간 동안 30℃에서 배양하고, 건조균체 농도, PHB 농도, 잉여건조균체 농도, PHB 함량 및 PHB 수율을 측정하였다. 복합질소원이 첨가되지 않은 단순배지에서의 배양결과를 대조군으로 하였으며, 상기의 측정결과를 하기 표 6에 나타내었다.The complex nitrogen source was added to the simple medium at the optimum concentration determined in Example 5-1, and then inoculated with E. coli XL1-Blue containing pSYL107 and incubated at 30 ° C. for 48 hours, followed by dry cell concentration, PHB concentration, and excess drying. Cell concentration, PHB content and PHB yield were measured. The result of culturing in a simple medium without a complex nitrogen source was used as a control, and the measurement results are shown in Table 6 below.

상기 표 6에서 보듯이, 소량의 복합질소원 첨가로 균체성장, PHB 생산능 및 PHB 함량을 증대시킬 수 있음을 알 수 있었다. 특히, 육즙 추출물(약어로 '바'에 해당) 5g/L로의 첨가시, 건조균체와 PHB 농도는 각각 8.68g/L와 7.46g/L이고, PHB 함량은 86%로서, 이는 복합배지에서 얻은 결과와 비슷함을 알 수 있다(참조: 표 3). 또한, 잉여건조균체의 농도는 복합질소원의 첨가에 따라 크게 변화하지 않았는데, 이로부터 복합질소원의 첨가가 균체의 성장은 약간만 향상시킨 반면, PHB 생산능은 크게 증대시킴을 알 수 있다. 복합질소원의 첨가시 PHB 생산능만이 증대된 것이 아니라, 포도당으로부터의 PHB 수율도 증가함을 확인하였는데, 이는 탄소원인 포도당을 PHB로 효과적으로 전환시키는 것을 의미한다.As shown in Table 6, it was found that the addition of a small amount of complex nitrogen source can increase the cell growth, PHB production capacity and PHB content. In particular, when added to the juice extract (abbreviation 'bar') 5g / L, the dry cell and PHB concentration was 8.68g / L and 7.46g / L, respectively, the PHB content is 86%, which is obtained in the mixed medium It is similar to the result (see Table 3). In addition, the concentration of the excess dry cells did not change significantly with the addition of the composite nitrogen source, from which it can be seen that the addition of the composite nitrogen source slightly increased the growth of the cells, while PHB production capacity greatly increased. It was confirmed that the addition of the complex nitrogen source not only increased PHB production capacity, but also increased the PHB yield from glucose, which means effectively converting the carbon source glucose into PHB.

이상에서 상세히 설명하고 입증하였듯이, 본 발명은 ftsZ 및 PHB 합성 유전자를 포함하는 재조합 플라스미드로 대장균을 형질전환시키고, 이 형질전환체로부터 고농도의 PHB를 제조하는 방법을 제공한다. 본 발명의 PHB 제조방법에 의하면, 필라멘테이션을 억제할 수 있는 ftsZ를 과다발현시킴으로써, 재조합 대장균에 의한 PHB 생산시 균체가 필라멘테이션에 의해 길어져서 세포의 성장이 둔화 혹은 정지되어, PHB의 생산성 및 PHB 수율이 낮아지는 문제점을 해결하여, 경제적으로 고농도의 PHB를 제조할 수 있다.As described and demonstrated in detail above, the present invention provides a method for transforming Escherichia coli with a recombinant plasmid containing ftsZ and PHB synthetic gene, and to prepare a high concentration of PHB from the transformant. According to the PHB manufacturing method of the present invention, by overexpressing ftsZ, which can suppress filamentation, the cells are lengthened by filamentation during PHB production by recombinant E. coli, thereby slowing or stopping cell growth, Solving the problems of low productivity and low PHB yield, it is possible to economically produce a high concentration of PHB.

Claims (1)

대장균의 필수 세포분열 단백질(ftsZ) 및 PHB(poly-3-hydroxybutyrate) 합성 유전자를 동시에 함유하는 재조합 플라스미드로 형질전환된 대장균(Escherichia coli)을 트립톤(tryptone) 10g/L, 효모 추출물(yeast extract) 5g/L, NaCl 10g/L 및 포도당 20g/L로 구성된 복합배지에서 28 내지 33℃의 온도조건으로 배양하여 PHB를 수득하는 단계를 포함하는 재조합 대장균으로부터 PHB를 제조하는 방법.Escherichia coli transformed with a recombinant plasmid containing both E. coli's essential cell division protein (ftsZ) and PHB (poly-3-hydroxybutyrate) synthetic genes were mixed with 10 g / L tryptone and yeast extract. A method for producing PHB from recombinant E. coli comprising the step of culturing at a temperature of 28 to 33 ℃ in a complex medium consisting of 5g / L, 10g / L NaCl and 20g / L glucose.
KR1019950017591A 1995-06-26 1995-06-26 Preparation method of phb by suppression of filamentation in recombinant escherichia coli KR0164282B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950017591A KR0164282B1 (en) 1995-06-26 1995-06-26 Preparation method of phb by suppression of filamentation in recombinant escherichia coli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950017591A KR0164282B1 (en) 1995-06-26 1995-06-26 Preparation method of phb by suppression of filamentation in recombinant escherichia coli

Publications (2)

Publication Number Publication Date
KR970001547A KR970001547A (en) 1997-01-24
KR0164282B1 true KR0164282B1 (en) 1999-01-15

Family

ID=19418397

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950017591A KR0164282B1 (en) 1995-06-26 1995-06-26 Preparation method of phb by suppression of filamentation in recombinant escherichia coli

Country Status (1)

Country Link
KR (1) KR0164282B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109468244A (en) * 2018-11-15 2019-03-15 中国科学院上海高等研究院 A kind of Escherichia coli of acid resistant form high-density growth and its application
CN111593078A (en) * 2020-06-03 2020-08-28 中粮营养健康研究院有限公司 Method for preparing PHA (polyhydroxyalkanoate) by fermenting corn steep liquor serving as raw material

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109468244A (en) * 2018-11-15 2019-03-15 中国科学院上海高等研究院 A kind of Escherichia coli of acid resistant form high-density growth and its application
CN111593078A (en) * 2020-06-03 2020-08-28 中粮营养健康研究院有限公司 Method for preparing PHA (polyhydroxyalkanoate) by fermenting corn steep liquor serving as raw material
CN111593078B (en) * 2020-06-03 2020-10-23 中粮营养健康研究院有限公司 Method for preparing PHA (polyhydroxyalkanoate) by fermenting corn steep liquor serving as raw material

Also Published As

Publication number Publication date
KR970001547A (en) 1997-01-24

Similar Documents

Publication Publication Date Title
Wang et al. Production of poly (3-hydroxybutyrate) by fed-batch culture of filamentation-suppressed recombinant Escherichia coli
Wang et al. High cell density culture of metabolically engineered Escherichia coli for the production of poly (3‐hydroxybutyrate) in a defined medium
Lee et al. Recent advances in polyhydroxyalkanoate production by bacterial fermentation: mini-review
Byrom Polymer synthesis by microorganisms: technology and economics
Wong et al. Poly-(3-hydroxybutyrate) production from whey by high-density cultivation of recombinant Escherichia coli
FI92717B (en) The bacterial strain of Escheria coli VKPM /BK <IMAGE> M/ B-3996 as a L-treonin producer
Aragão et al. Maintaining a controlled residual growth capacity increases the production of polyhydroxyalkanoate copolymers by Alcaligenes eutrophus
Yup Lee Poly (3-hydroxybutyrate) production from xylose by recombinant Escherichia coli
Kim et al. Production of poly-β-hydroxybutyrate by fed-batch culture of recombinant Escherichia coli
US8071355B2 (en) Polyhydroxyalkanoate production by coenzyme A-dependent aldehyde dehydrogenase pathways
EP3741840A1 (en) Transformed microorganism for producing pha copolymer comprising 3hh monomer unit at high composition rate and method for producing pha using same
Lee et al. Production of microbial polyester by fermentation of recombinant microorganisms
Heinrich et al. From waste to plastic: synthesis of poly (3-hydroxypropionate) in Shimwellia blattae
KR0164282B1 (en) Preparation method of phb by suppression of filamentation in recombinant escherichia coli
Kobayashi et al. Fermentative production of P (3HB-co-3HV) from propionic acid by Alcaligenes eutrophus in fed-batch culture with pH-stat continuous substrate feeding method
KR100199994B1 (en) Process for preparing phb from xylose using recombinant e. coli
EP1154021B1 (en) Polyhydroxyalkanoate synthase and gene encoding the same enzyme
Yoo et al. Effect of pH on the production of lactic acid and secondary products in batch cultures of Lactobacillus casei
KR100241183B1 (en) Recombinant e.coli which produce phb from whey, and method of phb
KR100199993B1 (en) Process for producing phb from lactose using recombinant e. coli
KR0122437B1 (en) Method for producing high density phb using fed-batch culture of recombinant e. coli
Yim et al. Effect of acetic acid on poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) synthesis in recombinant Escherichia coli
KR100313561B1 (en) Recombinant Escherichia coli expressing the polyhydroxyalkyl acid biosynthesis enzyme of alkaline generators and method for producing polyhydroxyalkyl acid using the same
AU707659B2 (en) A recombinant Escherichia coli producing poly-3-hydroxybutyrate (PHB) and a process for preparing PHB employing the same
KR20070096347A (en) Mutants having a producing ability of 4-hydroxybutyrate and method for preparing 4hb using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110901

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee